# FDA Inspection 1240749 - Krzysztof Szymanowski, M.D. - May 17, 2024

Source: https://www.keypedia.com/records/fda_inspections/krzysztof-szymanowski-md/8fbe4d16-70ad-4a10-bc8f-d71ad43b6d06
Source feed: FDA_Inspections

> FDA Inspection 1240749 for Krzysztof Szymanowski, M.D. on May 17, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240749
- Company Name: Krzysztof Szymanowski, M.D.
- Inspection Date: 2024-05-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/krzysztof-szymanowski-md/ad7298bd-3240-436b-beb7-1e728c258ef5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
